Sandmaier 1999.

Methods	Uncontrolled phase II study
Participants	40 breast or ovarian cancer (n = 7) patients who underwent high‐dose chemotherapy and autologous or syngeneic stem cell rescue (disease status at study entry unknown)
Interventions	Subcutaneous KLH conjugate (Sialyl‐Tn) Adjuvant: Detox B
Outcomes	Immune responses: humoral, cellular
Notes
Risk of bias
Bias	Authors' judgement	Support for judgement
Random sequence generation (selection bias)	High risk	Uncontrolled trial
Allocation concealment (selection bias)	High risk	Uncontrolled trial
Blinding of participants and personnel (performance bias) All outcomes	Unclear risk	Information insufficient to permit judgement of ‘low risk’ or ‘high risk’
Blinding of outcome assessment (detection bias) All outcomes	Unclear risk	Information insufficient to permit judgement of ‘low risk’ or ‘high risk’
Incomplete outcome data (attrition bias) All outcomes	Unclear risk	Information insufficient to permit judgement of ‘low risk’ or ‘high risk’
Selective reporting (reporting bias)	Unclear risk	Information insufficient to permit judgement of ‘low risk’ or ‘high risk’
Other bias	Unclear risk	Information insufficient to permit judgement of ‘low risk’ or ‘high risk’